Polyrizon Ltd. Ordinary Shares (PLRZ)

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$10.01

-0.40 (-3.84%)

Market Cap: $25.28M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Jul 1, 2026Reported Jul 1	$N/A	N/A	-	N/A	Beat	-	-	-
Mar 31, 2026Mar 26 Reported Jun 24, 2026Reported Jun 24	$N/A	N/A	-	N/A	Beat	-	-	-
Jun 30, 2025Jun 25 Reported Sep 17, 2025Reported Sep 17	$-0.74	$0.00	-	N/A	Miss	-	-	-
Dec 31, 2024Dec 24 Reported Mar 11, 2025Reported Mar 11	$-72.60	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	-2.59x	FCF Yield	-38.67%
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-21.40%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	36.37x	Quick Ratio	36.37x
Trading Statistics
Beta	N/A	Avg Volume	30.01K
52-Week High	$18.20	52-Week Low	$2.88

Technical Indicators Dashboard

Moving Averages

SMA 10$9.48

SMA 20$10.09

SMA 50$10.88

SMA 200$12.81

EMA 10$9.77

EMA 20$10.07

EMA 50$10.85

EMA 200$28.36

MACD

Line: -0.43Signal: -0.51Hist: 0.07

ADX

ADX: 17.1+DI: 22.2-DI: 16.5

Aroon & PSAR

Aroon Up36.0

Aroon Down92.0

PSAR$8.14

Bollinger Bands

Upper Band$11.56

Lower Band$8.61

%B Position2926%(Upper)

Band Width0.47

RSI (14-Day)

Neutral

47.5

Momentum Oscillators

Stoch %K58.5

Stoch %D45.7

Williams %R-43.9

ROC (10d)-3.0%

Momentum-0.31

CCI (20d)8.1

MFI (14d)42.3

Volatility Measures

ATR (14d)$1.06(10.6%)

StdDev (20d)0.74

Hist Vol68.0%(High)

Volume Flow

VWAP$10.16

OBV-1.2B

AD Line58330.7B

CMF (20d)-0.034

Volume Metrics

Avg Vol (20d)24.4K

Vol Ratio3.0x(High)

VWMA (20d)$10.10

Pivot Points

R3$13.52

R2$12.55

R1$11.48

Pivot Point$10.51

S1$9.44

S2$8.47

S3$7.40

Advanced Oscillators

TSI-14.78

Ultimate Osc51.3

KST-144.27

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Jun 2023
Total Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	$153,000	N/A	$153,000	N/A	$189,000	N/A	$117,000	N/A	$1,000	N/A	$2,000	$2,000
Gross Profit	$-153,000	N/A	$-153,000	N/A	$-189,000	N/A	$-117,000	N/A	$-1,000	N/A	$-2,000	$-2,000

Operating Expenses	$4.17M	$2.16M	$3.61M	$1.88M	N/A	N/A	$838,000	N/A	$346,000	N/A	$308,000	$323,000
R&D	$1.38M	$691,000	$1.36M	$678,500	$388	$388	$397,000	$0	$137,000	$0	$160,000	$172,000
SG&A	$0	$1.47M	$0	$1.20M	$0	$0	$441,000	$279	$209,000	$105	$148,000	$0
Operating Income	$-4,324,000	$-2,162,000	$-3,764,000	$-2,487,485	N/A	N/A	N/A	N/A	$-347,000	N/A	$-310,000	$-325,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$4,000	$0	$3,000	$0	$3.14M	$1.52M	$2,000	$0	$241,000	$0	$99,000	$0
Income Before Tax	$-1,424,000	$-712,000	$-3,158,000	$-176,823	$0	$0	$0	$0	$-588,000	$-294	$-409,000	$-191,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-1,424,000	$-712,000	$-3,158,000	$-176,823	N/A	N/A	$-957,000	N/A	$-588,000	$-294	$-409,000	$-191,000

EBITDA	$-4,171,000	$-2,085,500	$-3,611,000	$-2,406,015	$-1,148	$-1,148	$-838,000	$-419	$-346,000	N/A	$-308,000	$-189,000
EBIT	$-4,324,000	$-2,162,000	$-3,764,000	$-2,482,515	N/A	N/A	$-955,000	N/A	$-347,000	N/A	$-310,000	$-191,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about PLRZ

News

Polyrizon Ltd (PLRZ-Q) Stock Price and News

This article provides stock information and recent news for Polyrizon Ltd (PLRZ-Q), a development stage biotech company specializing in intranasal drug delivery platforms. It lists various news headlines from September...

The Globe and Mail•Oct 9, 2026 12:10 PM ET10/9/26•Bullish

Polyrizon files U.S. patent application for nasal drug delivery

Polyrizon Ltd. has filed a U.S. divisional patent application for its mucoadhesive technology platform, specifically for nasal drug delivery. This application...

Investing.com•Oct 6, 2026 10:03 PM ET10/6/26•Bullish

Polymers designed to coat tissue underpin Polyrizon (PLRZ)'s new U.S. patent application.

Polyrizon Ltd. (PLRZ) has filed a new U.S. divisional patent application titled “Mucoadhesive Polymers for Nasal Drug Delivery,” expanding its intellectual property related to its proprietary mucoadhesive technology....

Stock Titan•Oct 5, 2026 10:03 PM ET10/5/26•Somewhat-Bullish

Polyrizon Ltd. Files New U.S. Divisional Patent Application for Mucoadhesive Polymers for Nasal Drug Delivery

Polyrizon Ltd. has filed a new U.S. divisional patent application for "Mucoadhesive Polymers for Nasal Drug Delivery," expanding its intellectual property portfolio. This application...

www.marketscreener.com•Oct 5, 2026 5:32 PM ET10/5/26•Bullish

Polyrizon files U.S. patent application for nasal drug delivery By Investing.com

Polyrizon Ltd. (NASDAQ:PLRZ) has filed a divisional patent application with the U.S. Patent and Trademark Office to expand intellectual property protection for its mucoadhesive technology platform...

Investing.com Canada•Oct 5, 2026 8:02 AM ET10/5/26•Bullish

PLRZ Valuation and Fair Value

P/FCF: -2.6x
P/B: 0.7x

See GNG's fair value

PLRZ Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -21.4%
FCF yield: -38.7%

PLRZ Competitors

Company	Ticker
Seres Therapeutics Inc	MCRB
Evaxion Biotech AS	EVAX
PetMed Express Inc	PETS
Shuttle Pharmaceuticals Inc	SHPH
SRx Health Solutions Inc.	SRXH
Immutep Ltd ADR	IMMP
India Globalization Capital Inc	IGC
Galecto Inc	GLTO

Sector: Healthcare

Frequently Asked Questions About PLRZ

Does PLRZ pay dividends?

Polyrizon Ltd. Ordinary Shares (PLRZ) does not currently pay a regular dividend.

What is PLRZ's market cap?

Polyrizon Ltd. Ordinary Shares (PLRZ) has a market capitalization of $25.28M with a current stock price of $10.01.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In